A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Duarte CA, Irvine CA, La Jolla CA, Atlanta GA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
New
Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
for
Prostate Cancer, Diagnosis
Location: Burlington MA, Albany NY
Sponsor: Albany Medical College
Sex: Male
Age: 18+
Code: NCT06517901
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation
for
Prostate Cancer
Location: Brooklyn NY, New York NY
Sponsor: NYU Langone Health
Sex: Male
Age: 40 - 70+
Code: NCT07203482
Recruiting
New
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
for
Metastatic Prostate Carcinoma,
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: Male
Age: 18+
Code: NCT05487846
Recruiting
New
PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound
for
Prostate Cancer
Location: New York NY
Sponsor: NYU Langone Health
Sex: Male
Age: 40 - 70+
Code: NCT07184970
Recruiting
New
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
for
Metastatic Castration-resistant Prostate Cancer,
Location: San Antonio TX
Sponsor: K36 Therapeutics, Inc.
Sex: Male
Age: 18+
Code: NCT07103018
Phase1, Recruiting
New
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),